This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Products Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Gérard Turpin: Innovator in Apolipoprotein Research
Introduction
Gérard Turpin is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the study of apolipoproteins. His work has implications for genetic therapy and pharmaceutical applications.
Latest Patents
Gérard Turpin holds 1 patent related to variants of apolipoprotein A-I. This patent focuses on variants of the human apolipoprotein A-I that include a cysteine at position 151. The invention encompasses the corresponding nucleic acids and vectors containing them. Additionally, it relates to pharmaceutical compositions that utilize these elements, particularly in gene therapy.
Career Highlights
Gérard Turpin is associated with Aventis Pharmaceuticals Products Inc., where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of apolipoproteins and their potential therapeutic applications.
Collaborations
Throughout his career, Gérard has collaborated with esteemed colleagues such as Patrick Benoit and Eric Bruckert. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Gérard Turpin's innovative work in the field of apolipoproteins highlights his role as a key figure in biotechnology. His contributions continue to influence advancements in genetic therapy and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile